Dr. Jain brings extensive experience in the biotech and pharma sectors and has been instrumental in driving innovation, vaccine development, and healthcare advancement
CEPI will commit up to US $50 million to fund preclinical research and Phase 1 clinical trials of Moderna’s mRNA-based vaccine candidate
An exploratory overall survival signal also leaned in favor of the combination, though the companies noted the result remains preliminary
While oncology contributed Rs. 16,100.9 million to remain company's largest therapy area, the key highlight was receipt of 11 new regulatory approvals for medicines and indications
We have the chance to build an IP estate that goes hand in hand with our generic pharmaceutical strength and build proprietary biological platforms
No approved vaccine or specific treatment currently available for Bundibugyo strain Ebola disease
The new CRS offering is delivered from WACKER’s Biotechnology Center in Munich
Union Health Minister highlights India’s progress in universal health coverage, digital health, AI strategy and global vaccine cooperation during plenary session in Geneva
Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics
The agreement targets a long-standing technical hurdle in the field: maintaining chemical purity as RNA constructs extend beyond 100 nucleotides
Subscribe To Our Newsletter & Stay Updated
